HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olle Stål Selected Research

Tamoxifen

5/2022PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patients.
1/2022Clinical and molecular characteristics of estrogen receptor-positive ultralow risk breast cancer tumors identified by the 70-gene signature.
2/2021Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer.
1/2021MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit.
1/2021Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial.
12/2020Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up.
5/2020Low RAB6C expression is a predictor of tamoxifen benefit in estrogen receptor-positive/progesterone receptor-negative breast cancer.
9/2019Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer.
2/2018Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer.
1/2018Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Olle Stål Research Topics

Disease

91Breast Neoplasms (Breast Cancer)
05/2022 - 01/2003
58Neoplasms (Cancer)
01/2022 - 07/2005
9Neoplasm Metastasis (Metastasis)
02/2021 - 08/2008
4Triple Negative Breast Neoplasms
12/2020 - 04/2010
3Carcinogenesis
02/2021 - 05/2005
2Colorectal Neoplasms (Colorectal Cancer)
10/2013 - 01/2013
1Inflammation (Inflammations)
02/2021
1Second Primary Neoplasms (Neoplasms, Second)
04/2017
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2017
1Lung Neoplasms (Lung Cancer)
04/2017
1Coronary Disease (Coronary Heart Disease)
04/2013
1Heart Diseases (Heart Disease)
04/2013
1Melanoma (Melanoma, Malignant)
10/2011

Drug/Important Bio-Agent (IBA)

61TamoxifenFDA LinkGeneric
05/2022 - 01/2003
35Estrogen ReceptorsIBA
01/2022 - 01/2003
24Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2005
17Biomarkers (Surrogate Marker)IBA
05/2021 - 01/2008
10Hormones (Hormone)IBA
05/2022 - 07/2005
10Progesterone Receptors (Progesterone Receptor)IBA
01/2022 - 07/2005
10Estrogens (Estrogen)FDA Link
09/2017 - 01/2003
9Phenobarbital (Luminal)FDA Link
05/2022 - 10/2012
7EnzymesIBA
05/2017 - 01/2005
5ErbB Receptors (EGF Receptor)IBA
12/2020 - 04/2010
5Phosphotransferases (Kinase)IBA
07/2019 - 01/2003
5Small Interfering RNA (siRNA)IBA
07/2019 - 05/2009
5Estrogen Receptor Modulators (Antiestrogen)IBA
04/2015 - 09/2005
5Cyclin D1IBA
06/2007 - 05/2005
4Estradiol (Delestrogen)FDA LinkGeneric
09/2017 - 08/2006
4Messenger RNA (mRNA)IBA
10/2015 - 12/2006
4Estrogen Receptor alphaIBA
01/2012 - 05/2006
4DNA (Deoxyribonucleic Acid)IBA
04/2011 - 11/2003
43 (or 17)-beta-hydroxysteroid dehydrogenaseIBA
03/2010 - 08/2006
3ParaffinIBA
11/2017 - 01/2013
3Oxidoreductases (Dehydrogenase)IBA
05/2017 - 03/2010
2Biological FactorsIBA
09/2019 - 01/2018
2Tyrosine (L-Tyrosine)FDA Link
07/2019 - 05/2009
2Trastuzumab (Herceptin)FDA Link
03/2019 - 04/2010
2Formaldehyde (Formol)FDA Link
11/2017 - 01/2013
2Dihydrotestosterone (Androstanolone)IBA
09/2017 - 05/2017
2AndrogensIBA
09/2017 - 05/2017
2MicroRNAs (MicroRNA)IBA
09/2017 - 01/2013
2Androgen Receptors (Androgen Receptor)IBA
05/2017 - 02/2016
2EstroneFDA Link
05/2017 - 08/2006
2Pharmaceutical PreparationsIBA
01/2017 - 03/2010
2LigandsIBA
06/2016 - 05/2014
2AntigensIBA
10/2013 - 08/2008
2Tyrosine Kinase InhibitorsIBA
10/2011 - 05/2009
2Aromatase (CYP19)IBA
04/2011 - 08/2006
2Serine (L-Serine)FDA Link
01/2011 - 03/2010
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
04/2010 - 07/2005
2human ERBB2 proteinIBA
05/2008 - 07/2005
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
06/2007 - 01/2005
2Cytochrome P-450 CYP2D6 (CYP2D6)IBA
01/2007 - 01/2005
1Histones (Histone)IBA
01/2022
1Epidermal Growth Factor (EGF)IBA
01/2022
1Aurora Kinase AIBA
01/2022
1Homeodomain Proteins (Proteins, Homeobox)IBA
01/2022
1inositol hexakisphosphate kinaseIBA
05/2021
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2021
1ProgranulinsIBA
02/2021
1sortilinIBA
02/2021
1Minichromosome Maintenance ProteinsIBA
01/2021
1Letrozole (Femara)FDA LinkGeneric
01/2021
1Protein Tyrosine PhosphatasesIBA
07/2019
1Regulatory-Associated Protein of mTORIBA
02/2018
1Dehydroepiandrosterone (DHEA)IBA
05/2017
1Androstenedione (4 Androstene 3,17 dione)IBA
05/2017
1Testosterone (Sustanon)FDA Link
05/2017
1ERRalpha Estrogen-Related ReceptorIBA
03/2016
14,17 beta-dihydroxy-4-androstene-3-oneIBA
10/2015
1Non-Receptor Type 2 Protein Tyrosine PhosphataseIBA
08/2015
1Ribosomal Protein S6 Kinases (S6 Kinase)IBA
06/2015
1TOR Serine-Threonine KinasesIBA
06/2015
1Transforming Growth Factor-beta Type II ReceptorIBA
04/2015
1CalciumIBA
01/2015
1Biological ProductsIBA
01/2015
1Mechanistic Target of Rapamycin Complex 1IBA
01/2015
1Erlotinib Hydrochloride (CP 358,774)FDA Link
05/2014
1GTP-Binding Proteins (G-Protein)IBA
05/2014
1AntibodiesIBA
11/2013
1EpitopesIBA
11/2013
12- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA
08/2013
1WW Domain-Containing OxidoreductaseIBA
04/2013
1Protein Isoforms (Isoforms)IBA
04/2013
1Retinoic Acid Receptor alphaIBA
01/2013
1Canertinib (CI 1033)IBA
10/2011
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
05/2011
1Forkhead Transcription Factors (Forkhead Box Proteins)IBA
04/2011
1p21-Activated KinasesIBA
03/2010
1RNA-Binding Proteins (RNA-Binding Protein)IBA
12/2009
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
05/2009
1TensinsIBA
05/2009

Therapy/Procedure

31Therapeutics
01/2021 - 01/2003
6Radiotherapy
06/2016 - 01/2005
2Aftercare (After-Treatment)
04/2017 - 04/2013
2Drug Therapy (Chemotherapy)
02/2009 - 05/2005
1Adjuvant Radiotherapy
11/2020
1Palliative Care (Palliative Therapy)
03/2019
1Segmental Mastectomy (Lumpectomy)
11/2017
1Mastectomy (Mammectomy)
11/2017